Have a personal or library account? Click to login
Matrix metalloproteinases polymorphisms as baseline risk predictors in malignant pleural mesothelioma Cover

Matrix metalloproteinases polymorphisms as baseline risk predictors in malignant pleural mesothelioma

Radiology and Oncology
Volume 52 (2018): Issue 2 (June 2018)
By: Danijela Strbac,  Katja Goricar,  Vita Dolzan and  Viljem Kovac  
Open Access
|Feb 2018

Authors

Danijela Strbac

Institute of Oncology Ljubljana, Ljubljana, Slovenia

Katja Goricar

Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Vita Dolzan

Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Viljem Kovac

vkovac@onko-i.si

Institute of Oncology Ljubljana, Ljubljana, Slovenia
DOI: https://doi.org/10.2478/raon-2018-0005 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 160 - 166
Submitted on: Dec 10, 2017
|
Accepted on: Dec 17, 2017
|
Published on: Feb 7, 2018
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
matrix metalloproteinases,
genetic polymorphism,
malignant mesothelioma
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2018 Danijela Strbac, Katja Goricar, Vita Dolzan, Viljem Kovac, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 52 (2018): Issue 2 (June 2018)Next article